STEMPOINT CAPITAL LP
NEW YORK, NY · CIK 1952142 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2022 · limited partnership
- Assets managed$761.3m
- Staff7 · 4 in investment roles
- Main clients (by assets)Private funds 85%, Companies 15%
- Private funds2 (2 hedge) · $584.4m gross assets
- Websitestempointcapital.com
- Form ADV · 2026-03-30SEC adviser record
- Legal entitySTEMPOINT CAPITAL LP (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundshedge 2
$310.6m
reported value
-0.8% vs Q1 2025
50positions
50.2%in top 10
18 new
16 added
15 reduced
20 sold out
vs Q1 2025
Options: 3 call positions ($980.1k notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SYNDAX PHARMACEUTICALS INC SNDX | $22.2m7.15% | Added +774.0k |
| IMMUNOVANT INC IMVT | $20.8m6.70% | Added +447.4k |
| SCHOLAR ROCK HLDG CORP SRRK | $18.7m6.02% | Reduced -38.1k |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $16.6m5.35% | Added +672.3k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $15.9m5.13% | Added +11.8k |
| MERUS N V MRUS | $14.0m4.51% | Reduced -80.7k |
| ARCELLX INC ACLX | $13.3m4.27% | Reduced -72.3k |
| CIDARA THERAPEUTICS INC CDTX | $13.0m4.18% | New |
| RHYTHM PHARMACEUTICALS INC RYTM | $11.2m3.60% | Added +142.9k |
| ALKERMES PLC ALKS | $10.0m3.23% | Added +158.8k |
| DENALI THERAPEUTICS INC DNLI | $9.9m3.19% | Added +40.8k |
| LEGEND BIOTECH CORP LEGN | $9.6m3.09% | New |
| GERON CORP GERN | $9.4m3.02% | Added +5.7m |
| ZAI LAB LTD ZLAB | $8.8m2.82% | Added +224.0k |
| MINERALYS THERAPEUTICS INC MLYS | $8.6m2.75% | New |
| UNIQURE NV QURE | $8.0m2.57% | Reduced -158.4k |
| ROIVANT SCIENCES LTD ROIV | $6.8m2.18% | Reduced -2.0m |
| AKERO THERAPEUTICS INC AKRO | $6.2m2.01% | Reduced -39.4k |
| INSMED INC INSM | $6.2m2.00% | Reduced -25.5k |
| SURROZEN INC SRZN | $6.1m1.98% | Added +445.7k |
| WAVE LIFE SCIENCES LTD 96663EUR | $5.9m1.88% | Added +810.5k |
| LENZ THERAPEUTICS INC LENZ | $5.4m1.74% | New |
| NUVALENT INC COM | $4.6m1.47% | Reduced -130.6k |
| KALVISTA PHARMACEUTICALS INC KALV | $4.4m1.41% | Reduced -47 |
| VISTAGEN THERAPEUTICS INC VTGN | $4.1m1.33% | Added +46.7k |
| APOGEE THERAPEUTICS INC COM | $3.7m1.18% | New |
| IDEAYA BIOSCIENCES INC IDYA | $3.5m1.12% | Added +98.9k |
| PROTARA THERAPEUTICS INC TARA | $3.5m1.12% | Reduced -46.9k |
| HELIX ACQUISITION CORP II BBOT | $3.3m1.06% | Added +114.9k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $3.1m1.00% | New |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $2.9m0.93% | Reduced -234.4k |
| REZOLUTE INC RZLT | $2.9m0.93% | New |
| TAYSHA GENE THERAPIES INC TSHA | $2.8m0.90% | New |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $2.8m0.89% | Added +48.1k |
| BIOHAVEN LTD BHVN | $2.5m0.79% | Reduced -75.8k |
| REGENERON PHARMACEUTICALS REGN | $2.5m0.79% | New |
| BRIDGEBIO PHARMA INC BBIO | $2.4m0.76% | Reduced -153.8k |
| JANUX THERAPEUTICS INC JANX | $2.1m0.67% | Reduced -252.1k |
| ORIC PHARMACEUTICALS INC ORIC | $2.0m0.66% | New |
| MBX BIOSCIENCES INC MBX | $1.6m0.52% | Added +44.4k |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $1.6m0.51% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $1.4m0.44% | New |
| GH RESEARCH PLC GHRS | $1.2m0.40% | New |
| TANGO THERAPEUTICS INC TNGX | $1.1m0.34% | New |
| PROTAGONIST THERAPEUTICS INC PTGX | $926.8k0.30% | Reduced -32.5k |
| TECTONIC THERAPEUTIC INC TECX | $794.8k0.26% | New |
| ADC THERAPEUTICS SA ADCT | $759.2k0.24% | New |
| VERONA PHARMA PLC VRNA | $700.6k0.23% | New |
| ABIVAX SA ABVX | $671.3k0.22% | New |
| MIND MEDICINE MINDMED INC COM NEW | $589.6k0.19% | New |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| REVOLUTION MEDICINES INC RVMD | $11.3m318.8k shares |
| XENON PHARMACEUTICALS INC XENE | $9.2m274.6k shares |
| CG ONCOLOGY INC CGON | $7.1m289.8k shares |
| SPRINGWORKS THERAPEUTICS INC SWTX | $7.0m159.3k shares |
| CYTOKINETICS INC CYTK | $6.0m149.6k shares |
| BLUEPRINT MEDICINES CORP BPMC | $5.5m61.9k shares |
| EDGEWISE THERAPEUTICS INC EWTX | $4.0m180.3k shares |
| ENLIVEN THERAPEUTICS INC ELVN | $2.4m120.4k shares |
| NEUROCRINE BIOSCIENCES INC NBIX | $2.3m21.1k shares |
| ASCENDIS PHARMA A/S | $2.3m14.7k shares |
| SPYRE THERAPEUTICS INC SYRE | $2.2m136.1k shares |
| AMICUS THERAPEUTICS INC FOLD | $2.2m268.9k shares |
| ARBUTUS BIOPHARMA CORP ABUS | $1.6m467.9k shares |
| OCULAR THERAPEUTIX INC OCUL | $912.8k124.5k shares |
| DYNE THERAPEUTICS INC DYN | $883.1k84.4k shares |
| SOLENO THERAPEUTICS INC SLNO | $797.0k11.2k shares |
| INFLARX NV IFRX | $739.5k725.0k shares |
| SOLID BIOSCIENCES INC SLDB | $733.2k198.2k shares |
| SIONNA THERAPEUTICS INC SION | $627.6k60.0k shares |
| BICARA THERAPEUTICS INC BCAX | $613.4k47.1k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ROIVANT SCIENCES LTD ROIV · Call | $617.6k915.0k shares | New |
| IMMUNOVANT INC IMVT · Call | $310.0k100.0k shares | New |
| GERON CORP GERN · Call | $52.5k300.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| CELLECTAR BIOSCIENCES INC CLRB · 13G · filed 2026-08-14 | 9.9%≈ $2.4m |
| XILIO THERAPEUTICS INC XLO · 13G · filed 2026-08-14 | 9.5%≈ $5.8m |
| XILIO THERAPEUTICS INC 13G · filed 2026-02-17 | 8.4% |
| SURROZEN INC SRZN · 13G · filed 2026-08-14 | 5.0%≈ $15.6m |